Kindred Biosciences downgraded by HC Wainwright & Co. with a new price target
$KIN
Major Pharmaceuticals
Health Care
HC Wainwright & Co. downgraded Kindred Biosciences from Buy to Neutral and set a new price target of $9.25 from $9.00 previously
Save time and jump to the most important pieces.